简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

2025-11-18 12:00

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Company to Present and Host 1x1 Investor Meetings on Tuesday, December 2nd, 2025

AUSTIN, Texas, November 18, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Chief Executive Officer Ryan Rhodes is scheduled to present and, together with Chief Financial Officer Ken Mobeck, will host 1x1 investor meetings at the upcoming Piper Sandler 37th Annual Healthcare Conference in New York City.

Date:                     Tuesday, December 2nd

Time:                  10:30-10:55 am ET (fireside discussion)

Format:                Fireside discussion and 1x1 investor meetings

Location:               The Lotte New York Palace 

Webcast:              https://event.webcasts.com/starthere.jsp?ei=1743759&tp_key=aa01607b94

The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.        
        

About EDAP TMS SA

A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.

Investor Contacts

Investor Relations
EDAP TMS SA
investor.relations@focalone.com

John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com


风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。